Tru Independence LLC Vaxart, Inc. Transaction History

Tru Independence LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$6.67 - $9.8 $145,085 - $213,169	-21,752 Closed	0 $0
Q1 2021 May 20, 2021	BUY	$5.64 - $23.33 $50,760 - $209,969	9,000 Added 70.58%	21,752 $190,000
Q4 2020 Mar 09, 2021	BUY	$3.5 - $7.98 $44,632 - $101,760	12,752 New	12,752 $72,000
Q3 2020 Nov 19, 2020	SELL	$4.78 - $16.97 $9,139 - $32,446	-1,912 Closed	0 $0
Q2 2020 Aug 19, 2020	BUY	$1.68 - $8.85 $3,205 - $16,885	1,908 Added 47700.0%	1,912 $17,000
Q4 2019 May 19, 2020	BUY	$0.28 - $0.39 $1 - $1	4 New	4 $0

107

36.2M

83.1K

120K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $53.1M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence LLC with notifications on news.